Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial
Status:
Recruiting
Trial end date:
2022-10-31
Target enrollment:
Participant gender:
Summary
PRACTECAL-PRO is a sub-study of a TB-PRACTECAL clinical trial for multidrug resistant
Tuberculosis. It evaluates the effectiveness of TB-PRACTECAL interventions from the patient
perspective in terms of their quality of life, shared decision making and satisfaction with
services.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Medecins Sans Frontieres, Netherlands
Collaborators:
Don McKenzie Hospitals, Kwazulu Natal, South Africa Doris Goodwin Hospitals, Kwazulu Natal, South Africa London School of Hygiene and Tropical Medicine Ministry of Health, Republic of Uzbekistan Ministry of Public Health, Republic of Belarus Republican Scientific and Practical Centre for Pulmonology and Tuberculosis hospital Republican specialised scientific-practical medical centre, Tashkent Republican TB Hospital No. 2, Nukus THINK TB & HIV Investigative Network University of Sussex Wits Health Consortium (Pty) Ltd
Treatments:
Bedaquiline Clofazimine Linezolid Moxifloxacin Norgestimate, ethinyl estradiol drug combination